Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) Peptid
CHRNA9
Reaktivität: Human, Huhn
Wirt: Synthetic
BP
-
- Target Alle CHRNA9 Produkte
- CHRNA9 (Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9))
- Spezies
- Human, Huhn
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP)
- Produktmerkmale
- The peptide is used to block Anti-CHRNA9 Antibody reactivity.
-
-
- Applikationshinweise
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Buffer
- Lyophilized powder
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year.
- Haltbarkeit
- 12 months
-
- Target
- CHRNA9 (Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9))
- Synonyme
- HSA243342 Peptide, NACHRA9 Peptide, 2410015I05Rik Peptide, Acra9 Peptide, EG666827 Peptide, Gm8311 Peptide, cholinergic receptor nicotinic alpha 9 subunit Peptide, cholinergic receptor, nicotinic, alpha polypeptide 9 Peptide, CHRNA9 Peptide, Chrna9 Peptide
- Hintergrund
- NACHRA9, Neuronal acetylcholine receptor subunit alpha-9, Nicotinic acetylcholine receptor subunit alpha-9, NACHR alpha-9
- Gen-ID
- 55584
- UniProt
- Q9UGM1
-
Sie sind hier:
